definiens: means BioWa ’s proprietary technology directly relating to the use of Potelligent ® Cells to produce Antibodies with enhanced ADCC activity by reducing the amount of fucose linked to the carbohydratechains, including ( i ) Potelligent ® Cells ; ( ii ) cell transfection methods, including methods for selection of transfectedcells ; ( iii ) protein expression, production or purification methods ; ( iv ) therapeutic compositions, formulations or usesof, and other modifications to, Antibodies with enhanced ADCC activity produced by transfected cells ; and ( v ) anymodifications to host cells producing glycoproteins with a reduced amount of fucose linked to such glycoproteins . Forthe purposes of clarity general technology that relates solely to the growth of cells or applies generally to antibodiesthat have not been fucose - reduced, even if it also applies to Potelligent ® Cells, is not included . For the purposes offurther clarity, a combined technology comprising Potelligent ® Technology offered in combination with technologyowned or Controlled by one or more Third Parties is also not Potelligent ® Technology